These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 9633824)

  • 1. IGF-I receptor protection from apoptosis in cells lacking the IRS proteins.
    Dews M; Nishimoto I; Baserga R
    Recept Signal Transduct; 1997; 7(4):231-40. PubMed ID: 9633824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of structural characteristics that contribute to a difference in antiapoptotic function between human insulin and insulin-like growth factor 1 receptors.
    Chen H; Yan GC; Gishizky ML
    Cell Growth Differ; 1998 Nov; 9(11):939-47. PubMed ID: 9831246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prolonged vs transient roles for early cell cycle signaling components.
    Rose DW; Xiao S; Pillay TS; Kolch W; Olefsky JM
    Oncogene; 1998 Aug; 17(7):889-99. PubMed ID: 9780005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of breast cancer cell motility by insulin receptor substrate-2 (IRS-2) in metastatic variants of human breast cancer cell lines.
    Jackson JG; Zhang X; Yoneda T; Yee D
    Oncogene; 2001 Nov; 20(50):7318-25. PubMed ID: 11704861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual regulation of upstream binding factor 1 levels by IRS-1 and ERKs in IGF-1-receptor signaling.
    Sun H; Tu X; Liu M; Baserga R
    J Cell Physiol; 2007 Sep; 212(3):780-6. PubMed ID: 17443674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential activation of insulin receptor substrates 1 and 2 by insulin-like growth factor-activated insulin receptors.
    Denley A; Carroll JM; Brierley GV; Cosgrove L; Wallace J; Forbes B; Roberts CT
    Mol Cell Biol; 2007 May; 27(10):3569-77. PubMed ID: 17325037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway.
    Zamorano J; Wang HY; Wang LM; Pierce JH; Keegan AD
    J Immunol; 1996 Dec; 157(11):4926-34. PubMed ID: 8943397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re-expression of estrogen receptor alpha in estrogen receptor alpha-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth.
    Oesterreich S; Zhang P; Guler RL; Sun X; Curran EM; Welshons WV; Osborne CK; Lee AV
    Cancer Res; 2001 Aug; 61(15):5771-7. PubMed ID: 11479214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutant IGF-I receptors as dominant negatives for growth and transformation.
    Burgaud JL; Resnicoff M; Baserga R
    Biochem Biophys Res Commun; 1995 Sep; 214(2):475-81. PubMed ID: 7677754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-operation of simian virus 40 T antigen and insulin receptor substrate-1 in protection from apoptosis induced by interleukin-3 withdrawal.
    Zhou-Li F; Xu SQ; Dews M; Baserga R
    Oncogene; 1997 Aug; 15(8):961-70. PubMed ID: 9285691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transformation by the simian virus 40 T antigen is regulated by IGF-I receptor and IRS-1 signaling.
    DeAngelis T; Chen J; Wu A; Prisco M; Baserga R
    Oncogene; 2006 Jan; 25(1):32-42. PubMed ID: 16170362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a mutation at tyrosine 950 of the insulin-like growth factor I receptor on the growth and transformation of cells.
    Miura M; Li S; Baserga R
    Cancer Res; 1995 Feb; 55(3):663-7. PubMed ID: 7834637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of the mitogenic and transforming activities of the insulin-like growth factor I receptor.
    Hongo A; D'Ambrosio C; Miura M; Morrione A; Baserga R
    Oncogene; 1996 Mar; 12(6):1231-8. PubMed ID: 8649825
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-like growth factor I signalling through heterodimers of insulin and insulin-like growth factor I receptors.
    Takata Y; Kobayashi M
    Diabete Metab; 1994; 20(1):31-6. PubMed ID: 8056133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in growth and apoptosis of insulin receptor substrate-1-deficient beta-cells.
    Hennige AM; Ozcan U; Okada T; Jhala US; Schubert M; White MF; Kulkarni RN
    Am J Physiol Endocrinol Metab; 2005 Aug; 289(2):E337-46. PubMed ID: 15827066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity.
    Rubin R; Baserga R
    Lab Invest; 1995 Sep; 73(3):311-31. PubMed ID: 7564264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor induces insulin receptor substrate-2 in breast cancer cells via c-Jun NH(2)-terminal kinase/activator protein-1 signaling to regulate cell migration.
    Cui X; Kim HJ; Kuiatse I; Kim H; Brown PH; Lee AV
    Cancer Res; 2006 May; 66(10):5304-13. PubMed ID: 16707456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mechanism for cell size regulation by the insulin and insulin-like growth factor-I receptors.
    Sun H; Tu X; Baserga R
    Cancer Res; 2006 Dec; 66(23):11106-9. PubMed ID: 17145851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin and IGF-I receptors signaling in protection from apoptosis.
    Prisco M; Romano G; Peruzzi F; Valentinis B; Baserga R
    Horm Metab Res; 1999; 31(2-3):80-9. PubMed ID: 10226786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.